BACKGROUND: Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) pose serious threats to the health of Canadians due to increased morbidity, mortality and healthcare costs. Epidemiologic and laboratory surveillance data, collected through the Canadian Nosocomial Infection Surveillance Program, are used to inform infection prevention and control and antimicrobial stewardship programs and policies. The objective of this study was to describe the epidemiologic and laboratory characteristics and trends of HAIs and AMR from 2014 to 2018 using surveillance data provided by Canadian hospitals participating in the Canadian Nosocomial Infection Surveillance Program. METHODS: Data were collected from 70 Canadian sentinel hospitals between January 1, 2014 and December 31, 2018 for Clostridioides difficile infection (CDI), methicillin-resistant Staphylococcus aureus bloodstream infections, vancomycin-resistant Enterococci bloodstream infections and carbapenemase-producing Enterobacteriaceae. Case counts, rates, outcome data, molecular characterization and antimicrobial resistance profiles are presented. Additionally, hospital-level Escherichia coli antibiogram data were collected and are described. RESULTS: Increases in rates per 10,000 patient-days were observed for methicillin-resistant S. aureus bloodstream infections (59%; 0.66-1.05, p=0.023) and vancomycin-resistant Enterococci bloodstream infections (143%; 0.14-0.34, p=0.023). However, CDI rates decreased by 12.5% between 2015 and 2018 (from 6.16-5.39, p=0.042). Carbapenemase-producing Enterobacteriaceae infection rates remained low and stable whereas colonization increased by 375% (0.04-0.19; p=0.014). CONCLUSION: Ongoing efforts to prevent HAIs and reduce AMR in Canada require consistent, standardized surveillance data from acute care hospitals. Increased collaboration with provincial, territorial and international partners in infection prevention and control, as well as antimicrobial stewardship, will be essential in reducing the burden of observed HAIs (including antimicrobial resistant organisms).
BACKGROUND: Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) pose serious threats to the health of Canadians due to increased morbidity, mortality and healthcare costs. Epidemiologic and laboratory surveillance data, collected through the Canadian Nosocomial Infection Surveillance Program, are used to inform infection prevention and control and antimicrobial stewardship programs and policies. The objective of this study was to describe the epidemiologic and laboratory characteristics and trends of HAIs and AMR from 2014 to 2018 using surveillance data provided by Canadian hospitals participating in the Canadian Nosocomial Infection Surveillance Program. METHODS: Data were collected from 70 Canadian sentinel hospitals between January 1, 2014 and December 31, 2018 for Clostridioides difficile infection (CDI), methicillin-resistant Staphylococcus aureus bloodstream infections, vancomycin-resistant Enterococci bloodstream infections and carbapenemase-producing Enterobacteriaceae. Case counts, rates, outcome data, molecular characterization and antimicrobial resistance profiles are presented. Additionally, hospital-level Escherichia coli antibiogram data were collected and are described. RESULTS: Increases in rates per 10,000 patient-days were observed for methicillin-resistant S. aureus bloodstream infections (59%; 0.66-1.05, p=0.023) and vancomycin-resistant Enterococci bloodstream infections (143%; 0.14-0.34, p=0.023). However, CDI rates decreased by 12.5% between 2015 and 2018 (from 6.16-5.39, p=0.042). Carbapenemase-producing Enterobacteriaceae infection rates remained low and stable whereas colonization increased by 375% (0.04-0.19; p=0.014). CONCLUSION: Ongoing efforts to prevent HAIs and reduce AMR in Canada require consistent, standardized surveillance data from acute care hospitals. Increased collaboration with provincial, territorial and international partners in infection prevention and control, as well as antimicrobial stewardship, will be essential in reducing the burden of observed HAIs (including antimicrobial resistant organisms).
Authors: Jeffery Ho; Sunny H Wong; Vijaya C Doddangoudar; Maureen V Boost; Gary Tse; Margaret Ip Journal: Am J Infect Control Date: 2019-08-03 Impact factor: 2.918
Authors: Andrew E Simor; Linda Pelude; George Golding; Rachel Fernandes; Elizabeth Bryce; Charles Frenette; Denise Gravel; Kevin Katz; Allison McGeer; Michael R Mulvey; Stephanie Smith; Karl Weiss Journal: Infect Control Hosp Epidemiol Date: 2016-01-19 Impact factor: 3.254
Authors: J Freeman; J Vernon; S Pilling; K Morris; S Nicholson; S Shearman; C Longshaw; M H Wilcox Journal: Clin Microbiol Infect Date: 2017-10-21 Impact factor: 8.067
Authors: Philipp P Kohler; Roberto G Melano; Samir N Patel; Shumona Shafinaz; Amna Faheem; Brenda L Coleman; Karen Green; Irene Armstrong; Huda Almohri; Sergio Borgia; Emily Borgundvaag; Jennie Johnstone; Kevin Katz; Freda Lam; Matthew P Muller; Jeff Powis; Susan M Poutanen; David Richardson; Anu Rebbapragada; Alicia Sarabia; Andrew Simor; Allison McGeer Journal: Emerg Infect Dis Date: 2018-09 Impact factor: 6.883
Authors: Carl Suetens; Katrien Latour; Tommi Kärki; Enrico Ricchizzi; Pete Kinross; Maria Luisa Moro; Béatrice Jans; Susan Hopkins; Sonja Hansen; Outi Lyytikäinen; Jacqui Reilly; Aleksander Deptula; Walter Zingg; Diamantis Plachouras; Dominique L Monnet Journal: Euro Surveill Date: 2018-11
Authors: Ross T Prager; Michael T Pratte; Laura H Thompson; Kylie E McNeill; Christina Milani; David M Maslove; Shannon M Fernando; Kwadwo Kyeremanteng Journal: Crit Care Explor Date: 2021-12-09
Authors: Tim Du; Kelly B Choi; Anada Silva; George R Golding; Linda Pelude; Romeo Hizon; Ghada N Al-Rawahi; James Brooks; Blanda Chow; Jun C Collet; Jeannette L Comeau; Ian Davis; Gerald A Evans; Charles Frenette; Guanghong Han; Jennie Johnstone; Pamela Kibsey; Kevin C Katz; Joanne M Langley; Bonita E Lee; Yves Longtin; Dominik Mertz; Jessica Minion; Michelle Science; Jocelyn A Srigley; Paula Stagg; Kathryn N Suh; Nisha Thampi; Alice Wong; Susy S Hota Journal: Emerg Infect Dis Date: 2022-04-26 Impact factor: 16.126
Authors: Daleen Loest; F Carl Uhland; Kaitlin M Young; Xian-Zhi Li; Michael R Mulvey; Richard Reid-Smith; Lauren M Sherk; Carolee A Carson Journal: Epidemiol Infect Date: 2022-06-29 Impact factor: 4.434
Authors: Kelly B Choi; Tim Du; Anada Silva; George R Golding; Linda Pelude; Robyn Mitchell; Wallis Rudnick; Romeo Hizon; Ghada N Al-Rawahi; Blanda Chow; Ian Davis; Gerald A Evans; Charles Frenette; Jennie Johnstone; Pamela Kibsey; Kevin C Katz; Joanne M Langley; Bonita E Lee; Yves Longtin; Dominik Mertz; Jessica Minion; Michelle Science; Jocelyn A Srigley; Paula Stagg; Kathryn N Suh; Nisha Thampi; Alice Wong; Jeannette L Comeau; Susy S Hota Journal: Infect Control Hosp Epidemiol Date: 2022-08-18 Impact factor: 6.520